Adam Park

407 total citations
8 papers, 346 citations indexed

About

Adam Park is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Adam Park has authored 8 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Cancer Research. Recurrent topics in Adam Park's work include NF-κB Signaling Pathways (2 papers), Fungal Plant Pathogen Control (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). Adam Park is often cited by papers focused on NF-κB Signaling Pathways (2 papers), Fungal Plant Pathogen Control (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). Adam Park collaborates with scholars based in United States, Australia and South Korea. Adam Park's co-authors include Vijay Baichwal, Robert Tjian, Andrew S. Neish, Tucker Collins, Levon M. Khachigian, Kun Peng, Stephen W. Young, Xiaoning Zhao, Keith R. Olson and Tom S. Wehrman and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Adam Park

8 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Park United States	6	231	103	73	55	53	8	346
Henric S. Adler Germany	9	318 1.4×	171 1.7×	89 1.2×	41 0.7×	29 0.5×	10	547
Bruno D. Fonseca Canada	8	477 2.1×	59 0.6×	74 1.0×	49 0.9×	27 0.5×	8	600
Sarla G. Aneja United States	6	410 1.8×	90 0.9×	53 0.7×	36 0.7×	25 0.5×	7	534
Jana V. Maier Germany	7	202 0.9×	72 0.7×	79 1.1×	54 1.0×	15 0.3×	9	342
C Odaka Japan	6	242 1.0×	179 1.7×	61 0.8×	37 0.7×	35 0.7×	8	427
Christiane Hecquet France	10	305 1.3×	47 0.5×	34 0.5×	46 0.8×	28 0.5×	12	437
Heinz Mueller Switzerland	12	365 1.6×	139 1.3×	155 2.1×	80 1.5×	28 0.5×	13	545
N Li China	6	328 1.4×	49 0.5×	102 1.4×	31 0.6×	25 0.5×	13	466
Hyun‐Jung Byun South Korea	12	257 1.1×	76 0.7×	105 1.4×	72 1.3×	50 0.9×	15	408
Hung‐Chi Cheng Taiwan	9	292 1.3×	87 0.8×	116 1.6×	78 1.4×	41 0.8×	15	455

Countries citing papers authored by Adam Park

Since Specialization

Citations

This map shows the geographic impact of Adam Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Park more than expected).

Fields of papers citing papers by Adam Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Park. The network helps show where Adam Park may publish in the future.

Co-authorship network of co-authors of Adam Park

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Park. A scholar is included among the top collaborators of Adam Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Park. Adam Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Kim, Hoe Suk, et al.. (2025). Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models. Breast Cancer Research. 27(1). 113–113. 2 indexed citations

2.

Powderly, John D., Paul L. de Souza, Lisa G. Horvath, et al.. (2019). AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced tumors: Preliminary results from ongoing phase I studies.. Journal of Clinical Oncology. 37(15_suppl). 2604–2604. 27 indexed citations

3.

Marubayashi, Sachie, Adam Park, Rajkumar Noubade, et al.. (2016). FLX925 Is a Rationally Designed FLT3, CDK4/6 Inhibitor with a Desirable Resistance Profile. Blood. 128(22). 2323–2323. 3 indexed citations

4.

Zhao, Xiaoning, Keith R. Olson, Kun Peng, et al.. (2008). A Homogeneous Enzyme Fragment Complementation-Based β-Arrestin Translocation Assay for High-Throughput Screening of G-Protein-Coupled Receptors. SLAS DISCOVERY. 13(8). 737–747. 56 indexed citations

5.

Park, Adam & Vijay Baichwal. (1996). Systematic Mutational Analysis of the Death Domain of the Tumor Necrosis Factor Receptor 1-associated Protein TRADD. Journal of Biological Chemistry. 271(16). 9858–9862. 63 indexed citations

6.

Neish, Andrew S., Levon M. Khachigian, Adam Park, Vijay Baichwal, & Tucker Collins. (1995). Sp1 Is a Component of the Cytokine-inducible Enhancer in the Promoter of Vascular Cell Adhesion Molecule-1. Journal of Biological Chemistry. 270(48). 28903–28909. 108 indexed citations

7.

Miao, Shichang, et al.. (1995). Stawamycin, a new pyrroloketoindane natural product from the cultures of Streptomyces sp.. Tetrahedron Letters. 36(32). 5699–5702. 11 indexed citations

8.

Baichwal, Vijay, Adam Park, & Robert Tjian. (1991). v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor. Nature. 352(6331). 165–168. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact